Premier Alternatives

Revalia Bio

West Haven, CT · Founded 2021 · Privately Held (backing)

Operator of a platform intended to redefine organ donation and reinvent drug development. Revalia Bio is based in West Haven, CT and was founded in 2021. It was valued at $35.3 million at its seed round in Oct 2024, the last priced event on record. It has raised $26.8 million across 1 recorded round; the latest was a $12.3 million early-stage round in Oct 2024.

PMV mark · valuation
$35.3M
Oct 2026
Priced at
its seed round
Oct 2024
Total raised
$26.8M
Last round
Early Stage VC
Oct 2024

Revalia Bio key facts

as of Oct 2026
  • Operator of a platform intended to redefine organ donation and reinvent drug development.
  • Revalia Bio is valued at approximately $35.3M as of Oct 2026, set at its seed round, Oct 2024; nothing has traded since, per PrivateMarketView’s mark.
  • It has raised $26.8M across 1 recorded rounds; the latest was Early Stage VC ($12.3M) in Oct 2024.
  • Notable investors include Creative Destruction Lab, Connecticut Innovations, BoxOne Ventures, Sierra Ventures, Overmatch (Austin) — 11 tracked in total.
  • Revalia Bio has filed 1 Form D with the SEC, most recently Nov 2024 ($12.3M sold to 32 investors).
  • Status: Privately Held (backing).
PrivateMarketView mark
LOW confidence
$35.3M

Valued at $35.3M at its seed round, Oct 2024. Nothing has traded since.

set by its last priced roundas of Oct 2026question about this number?
Free account
More of Revalia Bio with a free account
  • ·The complete investor list: 11 names
  • ·Watch Revalia Bio: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Revalia Bio funding rounds

1 rounds
Oct 2024Early Stage VC$12.3MSEC filing▮
Full funding history →

Revalia Bio valuation

Revalia Bio was valued at $35.3 million at its seed round in Oct 2024. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Revalia Bio raised?

Revalia Bio has raised $26.8 million in total; 1 of its rounds is on record. The largest on record was a $12.3 million early-stage round in Oct 2024.

Revalia Bio has filed 1 Form D with the SEC, most recently in Nov 2024 ($12.3 million sold to 32 investors).

Revalia Bio investors

11 investors are on record for Revalia Bio, including Creative Destruction Lab, Connecticut Innovations, BoxOne Ventures and Sierra Ventures. The early-stage round in Oct 2024 drew 32 investors.

About Revalia Bio

Operator of a platform intended to redefine organ donation and reinvent drug development. The company specializes in biotechnology research through clinical trials without patients, personalizes care delivery, and precision drug targeting, enabling scientists, engineers, and innovators to build technologies that matter for patients.

Sector
Healthcare
HQ
West Haven, CT, United States
Founded
2021
Employees
26
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.